{"schema_version":"1","generated_at":"2026-10-28T08:08:11.884Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kevin-kelly","json_url":"https://www.findmykol.com/kol/kevin-kelly/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kevin-kelly","name":"Kevin Kelly","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1093963712"},"summary":"Kevin Kelly is an Oncology physician. ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05514990","title":"Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Southern California","source_url":"https://clinicaltrials.gov/study/NCT05514990","trial_url":"https://www.findmykol.com/trial/NCT05514990"},{"nct":"NCT04190550","title":"Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT04190550","trial_url":"https://www.findmykol.com/trial/NCT04190550"},{"nct":"NCT03330821","title":"Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Southern California","source_url":"https://clinicaltrials.gov/study/NCT03330821","trial_url":"https://www.findmykol.com/trial/NCT03330821"}],"source":"trials"},"payments":{"company_count":27,"program_years":{"first":2021,"last":null},"rows_total":52,"shown":3,"withheld":49,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":39797.66,"payment_count":32,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093963712"},{"payer":"Lilly USA, LLC","program_year":2025,"amount_usd":13377.55,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093963712"},{"payer":"ADC THERAPEUTICS AMERICA, INC.","program_year":2025,"amount_usd":13346.81,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093963712"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1093963712","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":51.5,"classes_total":1,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":51.5,"drugs":[{"name":"Revlimid","share_pct":47.1},{"name":"Lenalidomide","share_pct":32.4},{"name":"Pomalyst","share_pct":20.6}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":25.8,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":25.8,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":11}]},{"area":"Anti-infectives","share_pct":12.9,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":4.5,"facility_pct":95.5},"source":"medicare"},"contact":{"address_1":"1441 EASTLAKE AVE","address_2":"8302E","city":"Los Angeles","state":"CA","zip":"900890112","phone":"323-865-3950","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1093963712","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":49}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-11-18","provider_certified":"2020-11-18","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}